0 items USD 0.00Search
Your search for "mrrpb5 global acute repetitive seizures drugs market size status forecast 2019 2025" gave back 1596744 results.
The global Acute Migraine Drugs market size was valued at USD 2165.3 million in 2023 and is forecast to a readjusted size of USD 3473.9 million by...
Catalog:
GIR
January 2024
Price: USD 3,480.00
Autism Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest...
Catalog:
Global Markets Direct
February 2022
Price: USD 2,000.00
The global Acute Ischemic Stroke Therapeutics Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030,...
Catalog:
MRRPB5
July 2024
Price: USD 2,900.00
Acute Ischemic Stroke (CIS), also known as Cerebral Infarction (CI), is due to the occlusion of the Cerebral artery caused by the Infarction of brain...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Interleukin 1 (IL1) - Drugs in Development, 2021 Summary According to the recently published report 'Interleukin 1 - Drugs in Development, 2021...
Catalog:
Global Markets Direct
March 2021
Price: USD 3,500.00
Acute myeloid leukemia is the second frequent type (after acute lymphocytic leukemia) of leukemia diagnosed in infants. About 15% of children from...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Summary Publisher estimates that the Benzodiazepine Drugs market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and with a...
Catalog:
HYR
April 2021
Price: USD 2,000.00
Summary The Benzodiazepine Drugs market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and with a CAGR of xx%. The base...
Catalog:
HYR
March 2021
Price: USD 2,000.00
The global Acute Bronchitis Treatment market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with...
Catalog:
GIR
August 2024
Price: USD 3,480.00
Gemtuzumab ozogamicin is a drug-linked monoclonal antibody (an antibody-drug conjugate) that was used to treat acute myeloid leukemia from 2000 to...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
A neurological disorder is any disorder of the nervous system. Structural, biochemical or electrical abnormalities in the brain, spinal cord or other...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Lennox–Gastaut syndrome (LGS) is a complex, rare, and severe childhood-onset epilepsy. It is characterized by multiple and concurrent seizure types,...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Midostaurin is a multi-targeted protein kinase inhibitor that has been investigated for the treatment of acute myeloid leukemia (AML),...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Panhematin is an iron-containing porphyrin with chlorine that can be formed from a haem group, such as haem b found in the haemoglobin of human blood...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
